Orialpha (BD-C)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Orialpha (BD-C), covering 2026-07-16 to 2026-07-16. Get the full timeline:
Most recent: Clinical Trial Results: A Phase I, Single-arm, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers [Phase 1]